ARTICLE
|
doi:10.20944/preprints202407.1032.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
anticoagulation monitoring; apixaban; atrial fibrillation; edoxaban; on label dosing; rivaroxaban
Online: 12 July 2024 (10:59:58 CEST)